284 related articles for article (PubMed ID: 30654454)
1. Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time.
Krieter DH; Kerwagen S; Rüth M; Lemke HD; Wanner C
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30654454
[TBL] [Abstract][Full Text] [Related]
2. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
[TBL] [Abstract][Full Text] [Related]
3. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.
Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L;
J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716
[TBL] [Abstract][Full Text] [Related]
4. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
6. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
[TBL] [Abstract][Full Text] [Related]
7. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
8. High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial.
Lima JD; Guedes M; Rodrigues SD; Flórido ACS; Moreno-Amaral AN; Barra AB; Canziani ME; Cuvello-Neto A; Poli-de-Figueiredo CE; Pecoits-Filho R; Nakao LS
J Nephrol; 2022 Jun; 35(5):1449-1456. PubMed ID: 35239175
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
[TBL] [Abstract][Full Text] [Related]
10. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
[TBL] [Abstract][Full Text] [Related]
11. The association of uremic toxins and inflammation in hemodialysis patients.
Hsu HJ; Yen CH; Wu IW; Hsu KH; Chen CK; Sun CY; Chou CC; Chen CY; Tsai CJ; Wu MS; Lee CC
PLoS One; 2014; 9(7):e102691. PubMed ID: 25051062
[TBL] [Abstract][Full Text] [Related]
12. Super high-flux hemodialysis provides comparable effectiveness with high-volume postdilution online hemodiafiltration in removing protein-bound and middle-molecule uremic toxins: A prospective cross-over randomized controlled trial.
Thammathiwat T; Tiranathanagul K; Limjariyakul M; Chariyavilaskul P; Takkavatakarn K; Susantitaphong P; Meesangnin S; Wittayalertpanya S; Praditpornsilpa K; Eiam-Ong S
Ther Apher Dial; 2021 Feb; 25(1):73-81. PubMed ID: 32356365
[TBL] [Abstract][Full Text] [Related]
13. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R
PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005
[TBL] [Abstract][Full Text] [Related]
14. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.
Chen X; Gao S; Ruan M; Chen S; Xu J; Xing X; Pan X; Mei C; Mao Z
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29921575
[TBL] [Abstract][Full Text] [Related]
15. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
17. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
[TBL] [Abstract][Full Text] [Related]
18. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
19. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
20. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
